Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal mesothelioma: patient selection and special considerations.

57 Median OS for cisplatin and mitomycin was 40.8 months and 10.8 months, respectively, although this difference did not reach statistical significance.

also in 111,027 other papers

DFS, PFS, and EFS showed a trend of better outcomes for those perfused with cisplatin, but likely due to the small number of patients in the study and shorter follow-up period of the cisplatin cohort, these differences were not significant.

also in 53,322 other papers